tm logo

Monitor this mark

View On USPTO

MAKING CANCER EXIT
Dead/Abandoned
ABANDONED - AFTER INTER-PARTES DECISION

after inter

on 14 Nov 2024

Last Applicant/ Owned by

Kiromic Biopharma, Inc.

7707 Fannin St., Ste. 140

Houston

TX

77054

Serial Number

98325991 filed on 21st Dec 2023

Registration Number

N/A

Correspondent Address

KAREN WON

KAREN WON MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC

BOSTON, MA 02111

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MAKING CANCER EXIT

Pharmaceutical research and development; Research and development in the field of cancer therapeutics; Research and development in the pharmaceutical and biotechnology fields.

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical research and development; Research and development in the field of cancer therapeutics; Research and development in the pharmaceutical and biotechnology fields.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98325991

Mark Type

No Service Mark

Attorney Docket Number

No 060851-400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
14th Nov 2024ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
14th Nov 2024OPPOSITION TERMINATED NO. 999999
14th Nov 2024ABANDONMENT - AFTER INTER PARTES DECISION
14th Nov 2024OPPOSITION SUSTAINED NO. 999999
28th Oct 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
28th Oct 2024OPPOSITION INSTITUTED NO. 999999
25th Sep 2024EXTENSION OF TIME TO OPPOSE RECEIVED
27th Aug 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Aug 2024PUBLISHED FOR OPPOSITION
07th Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED